Figure 4From: High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanomaKaplan-Meier estimates of disease free and melanoma-specific survival in combined strata of high and low MCM3 and RBM3 expression. The impact of combined categories low and high expression of MCM3 and RBM3 expression, respectively, on (a) disease free survival and (b) melanoma-specific survival.Back to article page